|
2005 CMSC
Annual Meeting
Navigating the World of Multiple Sclerosis
June 1-5
Walt Disney Dophin Hotel
Orlando, Florida
Note: All the presentations were converted to Adobe PDF. Copying
and editing functions were disabled.
If you don"t have Adobe Reader, please go to www.adobe.com for a free download.
- Fundamentals
Fundamentals of MS Care and Management: Diagnosis to Rehabilitation
- Overview
of MS (Basic)
Stephen Rosenberg, MD, FAAN
- Disease
Modifying Therapies and Relapse Management
Ben Thrower, MD
- Symptom Management in MS
Tracy Walker, RN, FNP-C
- MS
Rehabilitation: Principles of Management
Patricia Bobryk, MHS, PT, MSCS
- Cognition,
Swallowing and Speech Issues in MS
Bonnie Schaude, MA, CCC-SLP
- The
Psychosocial Impact of MS
Cathy-Lee Benbow, MSW, RSW
- Hope
Linda Morgante, RN, MSN, CRRN, MSCN
- Lectures
- Research Lecture: Is MS a Neurodegenerative Disease?
Bruce Trapp, PhD
- LACTRIMS Lecture: Is MS Different in Latin America?
Edgardo Cristiano, MD, FAAN
- Presidential Lecture: The Potential for Remyelination in MS
Cedric Raine, PhD, DSc
- Angiogenesis and VEGF in EAE and MS: Is it Good, Bad or an Epiphenomenon?
Joseph Frank, MD
- Symposia
- Diagnosing MS in 2005: Focus and Accuracy
- Introduction and Review of Current Criteria
Mark Freedman, BSc, MSc, MD, CSPQ, FRCPC
- The
First Identifiable Demyelinating Event
Fiona Costello, MD, FRCP
- The Use of Serological or Cerebrospinal Fluid Diagnostic Tests
Mark Freedman, BSc, MSc, CSPQ, FRCPC
- Evoked
Potentials for Evaluation of MS
Bibliography
Peter Fuhr, MD
- Making the Most of MRI for Diagnosing MS
Anthony Traboulsee, MD, FRCPC
- Rehabilitation in MS: The Evidence
- Effectiveness
of Energy Conservation Education for People with MS
References
Marcia Finlayson, PhD, OTR/L, MSCS
- Effects of Aerobic Exercise on Fitness and Function of Patients
with MS
Eduard Gappmaier, PT, PhD
- Evidence
for Management of Dysarthria and Cognitive-Communication Problems
in MS: Development of Practice Guidelines in Speech Pathology
Kathryn Yorkston, PhD
- Consensus Statement of Standardized Functional Outcome Measures
in MS
Susan Bennett, PT, EdD, NCS, MSCS
- Pregnancy & MS: What We Know and What We Need to Learn
- Pregnancy in MS
Prof. Christian Confavreux, PhD
- Reproductive
Counselling
Colleen Guimond, MSc, CGC
- Disease Specific vs. Drug Specific Pregnancy Registries
Vincent Armenti, MD, PhD
- Where Do We Go From Here?
A. Dessa Sadovnick, PhD
- Primary Progressive MS
- Diagnosis
and Prognosis
Jerry Wolinsky, MD
- MR Imaging and Pathological Correlates
Daniel Pelletier, MD
- Lessons Learned from Trials Past
Emmanuelle Waubant, MD, PhD
- Rituximab and other Ongoing Trials
Kathleen Hawker, MD
- Neurocognitive
Retraining in MS
- Review of Neuropsychology of MS
Cynthia Sullivan, PhD
- Current Treatment Options for MS-Related Cognitive Dysfunction
Jeffrey Wilken, PhD
- Neurocognitive Retraining in MS
Iris-Katharina Penner, MD
- Research Against the Use of Cognitive Retraining in MS
Mary Quig, PhD
- Real World Issues in Cognitive Retraining
Pat Bednarik, MS, CCC-SLP, MSCS
- Alternative Medicine and MS
- Overview
of Recent MS-Relevant Stduies
Allen Bowling, MD, PhD
- Vitamin D, Hygiene Hypothesis and MS
John Fleming, MD
- Placebo Effects: Clinical Perspectives and Mechanisms
Barry Oken, MD
- The Role of Placebo in MS Clinical Trials, Past and Future
Ludwig Achim Kappos, MD
- Evolution of the MS Lesions
- Understanding MS Through Pathology
Samuel Ludwin, MD
- The Evolution of the Immune Response in MS
Anne Cross, MD
- Humoral Immunity as a Biomarker in MS
Claude Genain, MD
- The History of MS in 9 Acts
Jock Murray, MD, FRCPC
- The Framing of a Disease
- From the Hand of God to the Mattress Greave - The Early Cases of
MS 1400-1868
- The Medical Descriptions of MS Before Charcot
- The Contributions of Charcot and his Students
- From Devine Intervention to Interferon - The History of Therapy
in MS
- The Search for Infection 1868-2005
- From Coincidence to the Human Genome - The History of Genetics and
MS
- The Growing Role of the Public in MS
- The Frame of the Disease in 2005
- Neuroprotection and Neurogeneration: New Avenues in the Treatement of
MS
- Neuroprotection and Neurogeneration: The Final Frontier
Dennis Bourdette, MD
- Sodium Channels, Glutamate Receptors and Neuroprotection: Old Drugs,
New Uses
- Stem
Cell: Hope or Hype
David Trisler, PhD
- Remodeling the Brain After Injury: FMRI and Neuroplasticity
Robert Shin, MD
- LACTRIMS
- Understanding and Treating Pediatric Multiple Sclerosis: Insights into
Pathobiology and Therapeutics
- Workshops
- Powerpoint Intermediate
Ric Goldenberg
- Sleep Disorders in MS
David Brandes, MS, MD, FAAN; Rock Heyman, MD
- Dilemmas
of Outcome Measures in Rehabilitation
Sandra Brunham, MSc(PT), MSCS, Susan Forwell, MS, PhD(OT); Deborah Miller,
PhD
- Legal Issues Related to Advanced Practice Nursing
- When
the Scales of Justice Tip
Rebecca Berg Solano, Esq.
- Encounters with the Legal System; Personal Perspectives
Marie Namey, RN, MSN, MSCN; Linda Morgante, RN, MSN, CRRN, MSCN
- Approach to the Male Patient with Newly Diagnosed MS
Teddi Scneider, APRN, FNP-C, CMSN
- Genomic Studies
- MS Microarrays
Bianca Weinstock-Guttman, MD
- Identifying
Genes Involved in MS
Bernadette Kalman, MD, PhD
- Proteomics: What Happens After DNA and RNA Synthesis
Anthony Reder, MD
- Ethno-cultural Concerns in MS Care
- Powerpoint Advanced
Ric Goldenrberg
- Mobility
Aids and Assistive Devices
- Ambulation and Transfer Aids
Patricia Provance, PT, MSCS
- Seating and Mobility for Comfort and Function
- Assistive Devices
Carrie Bruce, MA, CCC-SLp, ATP
- Advanced Practice MS Nursing: The Challenges of Progressive Disease
Across Lifespan
- Cognitive
Therapy: Practical Skills for Coping with Illness and Loss
Jennifer Rodgers, PhD
- Nurturing your Children / Coping with Chronic Illness
MS Coaliton; Hellen Egger, MD; Lara Krawchuck, MSW, LSW, MPH
- Immunology of MS
Avertano Noronha, MD
- Caring for People
- Living with Advanced MS: What do Patients and Their Caregivers Care
About Most?
David Grunewald, MD
- Patient Preferences and Attitudes Regarding End of Life Decisions
in MS
James Bowen, MD
- Key Issues in Symptom Management in Advanced MS
Christopher Bever, MD
- How
to Set-up Neurology-Based Infusion Capabilities: Rationale and Guidelines
for the Administration of IV Therapies in the Treatment of MS
- The Rationale and Decision-Making Process: Is it Feasible?
Howard Rossman, DO
- Considerations and Potential Pitfalls: Our Experience
Sonda Lawson, MA, LLPC
- Infusion Services in the Neurologists Office: A Nursing Perspective
Mary Smithson, BSN, MSCN
- Mini-Courses
- Clinical Trials Management
- MRI Insights into MS Pathology
- Neurology for the Non-Neurologist
MS
Clinical Syndromes: Lesion Localization and A&P
Lynn McEwan, RN, MScN, CNNC, MSCN
- Botulinum Toxin for the Treatment of Spasticity in MS
- Does My Patient Need a Baclofen Pump?
- ITB Therapy: Medical Issues
Francois Bethoux, MD
- ITB Therapy: Nursing Issues
Danni Gogol, CNS/NP, LPC
- ITB Therapy and Rehabilitation
Mathhew Sutliff, PT
- Guiding
Your Patients Through the World of MS: A Patient Resource Center
- Benefits of a Patient Resource Center
Karen Nichols, MEd, CHES
- Integration into Clinical Practice: Patient Resource Center
Claire Hara-Cleaver, RN, MSN
- Visual
Dysfunction in Multiple Sclerosis
Robert Shin, MD; Janet Rucker, MD; Fiona Costello, MD, FRCP
- MS Research Using the CMSC/NARCOMS Database
Denise Campagnolo, MD; Ruth Ann Marrie, MD; Tuula Tyry, PhD, MAED
- Whitaker Track
|